• InterView
• Leclaza's ASCO data is like a global champion
• by An, Kyung-Jin May 28, 2021 06:08am

• InterView
• IQVIA provides a total solution based on big data
• by Eo, Yun-Ho May 20, 2021 05:41pm

• InterView
• "The reason why BI is the ‘Crown Jewel’ among all MNCs"
• by Eo, Yun-Ho May 10, 2021 06:22pm

• InterView
• "Embrace precision medicine and tumor-agnostic therapy"
• by Eo, Yun-Ho Apr 30, 2021 06:12am

• InterView
• KRPIA will introduce advanced new drugs and seek co-growth
• by Eo, Yun-Ho Apr 26, 2021 05:52am

• InterView
• “Amgen knows how to do it right in Korea”
• by Eo, Yun-Ho Mar 25, 2021 05:59am

• InterView
• “High pressure and hopes in the policy affairs at KRPIA"
• by Eo, Yun-Ho Mar 11, 2021 06:07am

• InterView
• There is still an unmet demand for antiviral drugs
• by Eo, Yun-Ho Mar 3, 2021 06:26am

• InterView
• Genexine Licenses out immuno-cancer Drug Technology
• by Kim, Jin-Gu Feb 22, 2021 06:17am

• InterView
• Takeda's evolution continues
• by Eo, Yun-Ho Feb 16, 2021 06:08am